|
601
|
|
|
Ankyrin repeat and fibronectin type III domain containing 1 |
WAKE |
|
|
602
|
|
|
Ankyrin repeat and FYVE domain containing 1 |
ANKHZN, BTBD23, ZFYVE14 |
|
|
603
|
|
|
ANKH inorganic pyrophosphate transport regulator |
ANK, CCAL2, CMDJ, CPPDD, HANK, MANK, SLC62A1 |
Alzheimer disease, Calcium metabolism disorders, Chondrocalcinosis, Craniofacial abnormalities, Craniometadiaphyseal dysplasia, Craniometaphyseal dysplasia, Desbuquois syndrome, Diabetes mellitus, Diabetic neuropathy, Endometriosis, Calcium pyrophosphate deposition, Glaucoma, Intellectual developmental disorder, Open angle glaucoma, Prostate cancer, Schwartz-lelek syndrome, Skeletal dysplasia, Tooth abnormalities, Diabetes mellitus, type 2View all (4 more) |
|
604
|
|
|
Ankyrin repeat and KH domain containing 1 |
MASK, MASK1, PP2500, VBARP |
|
|
605
|
|
|
ANKHD1-EIF4EBP3 readthrough |
MASK-BP3, MASK-BP3ARF |
|
|
606
|
|
|
Ankyrin repeat and IBR domain containing 1 |
- |
|
|
607
|
|
|
Ankyrin repeat and kinase domain containing 1 |
PKK2, sgK288 |
Anxiety disorder, Attention deficit hyperactivity disorder, Bipolar disorder, Major depressive disorder, Language development disorders, Metabolic syndrome, Mild cognitive impairment, Neurotic disorder, Schizophrenia, Diabetes mellitus, type 2 |
|
608
|
|
|
Ankyrin repeat and LEM domain containing 1 |
ANKRD41, LEM3, LEMD6 |
|
|
609
|
|
|
Ankyrin repeat and LEM domain containing 2 |
KIAA0692, LEMD7, Lem4, MCPH16 |
|
|
610
|
|
|
Ankyrin repeat and MYND domain containing 2 |
ZMYND20 |
|